Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis
Angelo Rossini(Centro Universitário Barão de Mauá), Elisabetta Cariani(University of Parma), Francesco Callea(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Antonella Ravaggi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Enrica Agostinelli(University of Brescia), L. Biasi(University of Brescia), Luisa Bercich(University of Brescia), Gian Biattista Gazzola(University of Brescia), E. Radaeli(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia)
Cited by 45
Related Papers
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
|Journal of Hepatology|2018|133
Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study
|The American Journal of Gastroenterology|2002|80
The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study
|Liver International|2016|76
Acute torsion of uterine leiomyoma: CT features
|Abdominal Imaging|2004|74